The global cardiac assist devices market is expected to reach USD XX million by 2022, growing at a CAGR of XX% from 2016 to 2022. Cardiac assist devices are electromechanical devices that assist the heart to improve pumping efficiency and maintain blood flow throughout the body. Ventricular assist devices replicate the heart functioning by pumping blood throughout the body and assist the heart in recovering its normal functioning. According to WHO, 17.5 million people deaths happen each year from CVDs and around 31% of all deaths globally. American Heart Association predicted that 600,000 new cases of heart failure are detected each year in the US and there is growing incidence of cardiac diseases in developing countries.
The United States has the largest market share in the global cardiac assist devices market. The increasing patient pool, favorable reimbursement policies in the United States and developed healthcare facilities are contributing to the largest market share. Due to technological advancement, it is expected that more efficient and minimally invasive devices are going to come up in the near future and drive the demand for cardiac assist devices.
Some of the factors driving the market for cardiac assist devices are:
While there is ample scope for growth in the global cardiac assist devices market, there are several factors restraining it as well. These include:
The global cardiac assist devices market has been segmented into intra-aortic balloon pump, total artificial heart, ventricular assist device, and circulatory support device market. The Ventricular assist device market has been further subdivided into left ventricular assist device, right ventricular assist device, bi-ventricular assist device, and external ventricular assist device. The ventricular assist devices have the largest market share amongst cardiac assist devices. The global cardiac assist device market has been segmented based on geography as North America, Europe, Asia-Pacific, Middle East and North Africa, and South America. The North America segment discusses different market trends, and market size of cardiac assist devices in the USA, Canada, and Mexico.
Some of the key players in this market include –
Some of the key players of this market are Abiomed Inc., Berlin Heart GmbH, Bioheart, Inc., Calon Cardio-Technology Ltd., Heartware, SynCardia Systems, Bivacor Pty Ltd., Braile biomedica Ltd., Calon cardio-technology Ltd., Cardiac assist, Inc., Cardiobridge Gmbh and many more.
Market definition for the cardiac assist devices market, along with identification of key drivers and restraints for the market.
Market analysis for the cardiac assist devices market, with region-specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
Identification and analysis of the macro and micro factors that affect the cardiac assist device market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.